Santos, F. P., Carvalhos, C. A., & Figueiredo-Dias, M. (2023). New Insights into Photobiomodulation of the Vaginal Microbiome-A Critical Review. International journal of molecular sciences. https://doi.org/10.3390/ijms241713507
Santos FP, Carvalhos CA, Figueiredo-Dias M. New Insights into Photobiomodulation of the Vaginal Microbiome-A Critical Review. International journal of molecular sciences. 2023. doi:10.3390/ijms241713507
Santos, Fernanda P., et al. "New Insights into Photobiomodulation of the Vaginal Microbiome-A Critical Review." International journal of molecular sciences, 2023.
For EndNote, Zotero or Mendeley:
Open access
No open license is recorded for this paper. Reuse terms are set by the publisher.
Open Access
Free full text on PubMed Central (PMC10487748)
RRM Academy Synopsis
Vaginal microbiome light therapy is a promising, early-stage field
A 2023 narrative review of photobiomodulation, a red or near-infrared light therapy, finds that light therapy for the vaginal microbiome is a theoretical and promising field taking its first steps. Much of the supporting work comes from the gut, the mouth and lab cells.
Key Findings
The authors call photobiomodulation of the microbiome a very new field and say its possible mechanisms remain largely theoretical.
Photobiomodulation can augment nitric oxide bioavailability. The review names nitric oxide as a central part of the vaginal immune response to bacterial vaginosis.
In breast cancer patients, infrared laser treatment of the abdomen was followed by an increase in beneficial gut bacteria.
Water-filtered infrared A could significantly reduce the infectivity of Chlamydia elementary bodies in two cell lines. Blue light of 415 nm showed anti-fungal effects on Candida in vitro.
ClinicalTrials.gov listed exactly 109 clinical studies of photobiomodulation on 28 July 2023, and research on light treatment of the microbiome is limited.
Interpretation
The paper is a narrative review. The authors gather laboratory, animal and human findings from the gut, mouth and cell cultures, then reason toward the vagina. They describe the vaginal application as promising but under-researched. They state that how light acts on the microbiome remains uncertain, and they ask for further studies of light parameters, effects and mechanisms.
RRM Context
The review cites links between vaginal dysbiosis, an imbalance of the microbiome, and pelvic inflammatory disease, infertility, miscarriage and preterm birth. RRM looks for underlying causes, so this microbiome is worth understanding. The authors call the vaginal application promising and ask for further studies.
Our editorial summary of this paper, not the article's abstract.
Abstract
The development of new technologies such as sequencing has greatly enhanced our understanding of the human microbiome. The interactions between the human microbiome and the development of several diseases have been the subject of recent research. In-depth knowledge about the vaginal microbiome (VMB) has shown that dysbiosis is closely related to the development of gynecologic and obstetric disorders. To date, the progress in treating or modulating the VMB has lagged far behind research efforts. Photobiomodulation (PBM) uses low levels of light, usually red or near-infrared, to treat a diversity of conditions. Several studies have demonstrated that PBM can control the microbiome and improve the activity of the immune system. In recent years, increasing attention has been paid to the microbiome, mostly to the gut microbiome and its connections with many diseases, such as metabolic disorders, obesity, cardiovascular disorders, autoimmunity, and neurological disorders. The applicability of PBM therapeutics to treat gut dysbiosis has been studied, with promising results. The possible cellular and molecular effects of PBM on the vaginal microbiome constitute a theoretical and promising field that is starting to take its first steps. In this review, we will discuss the potential mechanisms and effects of photobiomodulation in the VMB.